New York State Common Retirement Fund Nuvation Bio Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Nuvation Bio Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 48,128 shares of NUVB stock, worth $112,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,128
Previous 48,128 -0.0%
Holding current value
$112,619
Previous $141,000 21.99%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$2.58 - $3.69 $384 - $549
149 Added 0.31%
48,128 $141,000
Q1 2024

May 07, 2024
SELL
$1.46 - $3.97 $281 - $766
-193 Reduced 0.4%
47,979 $175,000
Q4 2023

Feb 01, 2024
SELL
$0.96 - $1.53 $273 - $436
-285 Reduced 0.59%
48,172 $73,000
Q3 2023

Nov 07, 2023
BUY
$1.26 - $2.1 $842 - $1,404
669 Added 1.4%
48,457 $65,000
Q2 2023

Aug 07, 2023
SELL
$1.56 - $1.84 $198 - $233
-127 Reduced 0.27%
47,788 $86,000
Q1 2023

May 02, 2023
SELL
$1.6 - $2.48 $55,040 - $85,312
-34,400 Reduced 41.79%
47,915 $80,000
Q4 2022

Jan 30, 2023
SELL
$1.68 - $2.5 $294 - $437
-175 Reduced 0.21%
82,315 $158,000
Q3 2022

Nov 08, 2022
BUY
$0.29 - $4.04 $21 - $303
75 Added 0.09%
82,490 $185,000
Q2 2022

Aug 04, 2022
SELL
$3.24 - $5.85 $59,091 - $106,692
-18,238 Reduced 18.12%
82,415 $267,000
Q1 2022

May 05, 2022
BUY
$4.6 - $8.83 $80,615 - $154,745
17,525 Added 21.08%
100,653 $529,000
Q4 2021

Feb 02, 2022
BUY
$7.75 - $10.05 $338,341 - $438,752
43,657 Added 110.61%
83,128 $707,000
Q3 2021

Nov 02, 2021
BUY
$7.78 - $10.0 $71,350 - $91,710
9,171 Added 30.27%
39,471 $392,000
Q2 2021

Aug 02, 2021
BUY
$9.22 - $14.48 $279,366 - $438,744
30,300 New
30,300 $282,000

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $508M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email